Trent Talks Through Potential Clinical Applications and Future Directions for MRD in GIST

In Partnership With:

Partner | Cancer Centers | <b>Sylvester Comprehensive Cancer Center, University of Miami</b>

Dr Trent discusses the current role and significance of using MRD in gastrointestinal stromal tumor, current guidelines around mutation testing, and research seeking to expand the targeted therapy armamentarium.

Welcome to OncLive On Air®! I’m your host today, Caroline Seymour.

OncLive On Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today’s episode, sponsored by Deciphera Pharmaceuticals, we had the pleasure of speaking with Jonathan C. Trent, MD, PhD, about potential clinical applications for minimal residual disease (MRD) in gastrointestinal stromal tumor (GIST) and upcoming trials and targets in the field. Trent is a professor and associate director for Clinical Research at the Sylvester Comprehensive Cancer Center, part of the University of Miami Health System in Florida.

In part 1 of our exclusive two-part interview, Dr Trent discussed the current role and significance of using MRD in GIST, current guidelines around mutation testing, and research seeking to expand the targeted therapy armamentarium.

____

That’s all we have for today! Tune in on August 17th to hear part 2. Thank you for listening to this episode of OncLive On Air®, sponsored by Deciphera Pharmaceuticals. Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field.

For more updates in oncology, be sure to visit www.OncLive.com and sign up for our e-newsletters.

OncLive® is also on social media. On Twitter, follow us at @OncLive. On Facebook, like us at OncLive, and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air®, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air®.

*OncLive On Air® is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.